par Sculier, Jean-Paul ;Bron, Dominique ;Delforge, Alain ;Body, Jean-Jacques ;Verboven, N;Fruhling, Janos ;Stryckmans, Pierre ;Klastersky, Jean
Référence La Presse médicale, 18, 23, page (1155-1158)
Publication Publié, 1989-06
Référence La Presse médicale, 18, 23, page (1155-1158)
Publication Publié, 1989-06
Article révisé par les pairs
Résumé : | Adoptive immunotherapy of cancer consists of using interleukin-2 to induce the formation of lymphokine-activated killer (LAK) cells which are toxic to tumoral cells. Six patients, 3 with hypernephroma and 3 with melanoma, were treated with interleukin-2. Drug toxicity consisted of capillary leakage syndrome in one case and reversible renal impairment in another. One patient showed an objective response; transient subjective improvement was observed in all patients. |